以高脂血症鹌鹑模型研究了市售红曲H-04和利用现代生物技术自制的新红曲H-18的血脂调节作用。结果显示，红曲H-04和红曲H-18均具有明显降低高脂血症鹌鹑血清总胆固醇（TC）、甘油三酯（TG）、低密度脂蛋白胆固醇（LDL-C）的作用；红曲H-18各剂量组对TG、LDL-C的降低作用大于红曲H-04相应剂量组，但统计学上无显著性差异；红曲H-18高剂量组和红曲H-04高剂量组对TC的降低作用有显著性差异（P＜0．05）。提示红曲H-18比红曲H-04具有更强的降血脂活性。

Studies on the effect of commercially available Hongqu H-04 and Hongqu H-18 made by ourself on blood lipid and lipoprotein concentration of quail suffering from hyperlipidaemia was carride out. Results demonstrated that the serum TC,TG, LDL-C concentrations in quail with hyperlipidaemia were significantly reduced by Hongqu H-04 and Hongqu H-18.The effect of Hongqu H-18 is better than Hongqu H-04 on blood lipid and lipoprotein concentration.